(Q48162906)

9 February 2018

title

Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry (English)

1 reference

9 February 2018

0 references

Jose de Leon

1

1 reference

9 February 2018

publication date

1 December 2014

1 reference

9 February 2018

published in

Acta Neuropsychiatrica

1 reference

9 February 2018

volume

26

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

327-333

1 reference

9 February 2018

Alzheimer's disease: A conceptual history

cites work

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

One hundred years of limited impact of Jaspers' General Psychopathology on US psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Is psychiatry scientific? A letter to a 21st century psychiatry resident

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Striving for coherence: psychiatry's efforts over classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Cure therapeutics and strategic prevention: raising the bar for mental health research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Personalized medicine in psychiatry: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Future in psychopathology research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Toward personalized medicine in the neuropsychiatric field

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Translational epidemiology in psychiatry: linking population to clinical and basic sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Systematic mutation analysis of KIAA0767 and KIAA1646 in chromosome 22q-linked periodic catatonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Overview of biomarkers and surrogate endpoints in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Psychiatry, the pharmaceutical industry, and the road to better therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

The concept of Schizophrenia. Kraepelin-Bleuler-Schneider.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

TOXICOLOGY AND THE BIOMEDICAL SCIENCES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Using genetics to enable studies on the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Alzheimer's disease: future treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

An international survey of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

The future (or lack of future) of personalized prescription in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

Drug development in the era of personalized oncology: from population-based trials to enrichment and prescreening strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

7 January 2021

DSM and the death of phenomenology in america: an example of unintended consequences

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

7 January 2021

Evidence-based medicine versus personalized medicine: are they enemies?

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

7 January 2021

DSM-5 and the research domain criteria: 100 years after Jaspers' General psychopathology.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

7 January 2021

Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.14

7 January 2021

Identifiers

DOI

10.1017/NEU.2014.14

1 reference

9 February 2018

1 reference

9 February 2018